Form 4 for VIR Vir Biotechnology, Inc.
Accepted 2025-11-04 00:00:00 ET · period of report 2025-11-03 · accession 0001628280-25-049159 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-04 | 2025-11-03 | VIR | de Verneuil Vanina | EVP, GC | S - Sale | $5.86 | -1,365 | 80.6K | -2% | -$7,999 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-03 | S | D | 1,365 | $5.86 | 80,595 | D | — | — | (F2) Includes 2,500 shares of common stock acquired by the Reporting Person on May 30, 2025 pursuant to an employee stock purchase program. |